Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Erythrocytic α‐Synuclein and the Gut Microbiome: Kindling of the Gut‐Brain Axis in Parkinson's Disease

5 Oct 2023

Abstract excerpt

BACKGROUND: Progressive spreading of α-synuclein via gut-brain axis has been hypothesized in the pathogenesis of Parkinson's disease (PD). However, the source of seeding-capable α-synuclein in the gastrointestinal tract (GIT) has not been fully investigated. Additionally, the mechanism by which the GIT microbiome contributes to PD pathogenesis remains to be characterized. OBJECTIVES: We aimed to investigate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Barrier Structure and Function Studies
Share to Gut microbiota and health
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37798868
DOI: 10.1002/mds.29620

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Erythrocytic α‐Synuclein and the Gut Microbiome: Kindling of the Gut‐Brain Axis in Parkinson's DiseasePMID 37798868Read ↗

Gut microenvironmental changes as a potential trigger in Parkinson’s disease through the gut–brain axisSemantic proximity Read ↗

Gut Microbiome and Its Role in Parkinson's DiseaseSemantic proximity Read ↗

Gut Vibes in Parkinson's Disease: The Microbiota‐Gut‐Brain AxisSemantic proximity Read ↗

Reduction of Short-Chain Fatty Acid-Producing Gut Microbiota Leads to Transition from Rapid-Eye-Movement Sleep Behavior Disorder to Parkinson’s DiseaseSemantic proximity Read ↗

Elucidating the dysbiotic features of gut microbiome, interaction with the human genome, and utility as a biomarker for treatment of Parkinson’s diseaseSemantic proximity Read ↗

α-synuclein overexpression and the microbiome shape the gut and brain metabolome in miceSemantic proximity Read ↗

The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorderSemantic proximity Read ↗

Impact of Nutrition on the Gut Microbiota: Implications for Parkinson’s DiseaseSemantic proximity Read ↗

α-Synuclein Overexpression and the Microbiome Shape the Gut and Brain Metabolome in MiceSemantic proximity Read ↗

Exploring human-genome gut-microbiome interaction in Parkinson’s diseaseSemantic proximity Read ↗

Gut microbiome dysbiosis across early Parkinson’s disease, REM sleep behavior disorder and their first-degree relativesSemantic proximity Read ↗

Gut microbiota, 1013 new pieces in the Parkinson's disease puzzleSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.